Brief: Kaléo Announces License Agreement With Amgen For Auto-Injector Technology
03/08/2026 13:18
BRIEF-Kaléo Announces License Agreement With Amgen For Auto-Injector Technology Aug 3 (Reuters) - Amgen Inc AMGN.O:
KALÉO ANNOUNCES LICENSE AGREEMENT WITH AMGEN FOR AUTO-INJECTOR TECHNOLOGY
KALÉO: AMGEN OBTAINED A LICENSE TO CERTAIN OF KALÉO'S PATENTED TECHNOLOGY ON AUTO-INJECTORS
KALÉO: FINANCIAL AND OTHER TERMS OF AGREEMENT WERE NOT DISCLOSED
Source text: ID:nGNXch0jtF
Further company coverage: AMGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amgen
See all newsUS RESEARCH ROUNDUP-Apple, Kaiser Aluminum, Reliance
Brief: Amgen Says Imdelltra Combo Reduced Risk Of Death By 58% In First-Line Lung Cancer
Corrected: Amgen drug combined with immunotherapy extends survival in lung cancer trial
US RESEARCH ROUNDUP- Amgen, Lockheed Martin, Norfolk Southern
Eli Lilly hits record high as healthcare stocks rally